Live
Long COVID
Long COVID or long-haul COVID is a group of health problems persisting or developing after an initial period of COVID‑19 from SARS-CoV-2 infection. Symptoms can last weeks, months, or years and are often debilitating. The World Health Organization defines long COVID as starting three months after the initial disease, but other agencies define it as starting at four weeks after the initial COVID-19.
114trials recruiting now
United Statesmost trial sites (47)
127mapped site locations
VA Office of Research most active sponsor
Trials by phase
Phase 1 tests safety, phase 2 tests whether it works, phase 3 compares it with standard care, phase 4 follows it after approval.
Countries with the most trials
Where trials are recruiting
Each dot is a site city; bigger dots have more recruiting trials. Showing up to 400 locations.
Lead sponsors
VA Office of Research and Development · 7Icahn School of Medicine at Mount Sinai · 4Technical University of Munich · 2National Taiwan University Hospital · 2Mayo Clinic · 2University of Alberta · 2University of California, San Francisco · 2ImmunityBio, Inc. · 2
Newest recruiting trials
- Phase 2
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
- Not applicable (device/behavioral)
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
- Not applicable (device/behavioral)
Observational Study With CICR-NAM as a Food for Special Medicinal Purposes in Post-COVID Syndrome (PCS)
- Not applicable (device/behavioral)
Micro-choice-based Intervention for Multicausal Fatigue
- Not applicable (device/behavioral)
Sauna for Long Covid
- Not applicable (device/behavioral)
SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition
- Phase 3
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
- Observational study
Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
- Observational study
Fatigue Investigation Using Digital Outcomes
- Phase 2
Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID
- Observational study
Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER)
- Phase 2
Sonlicromanol in Post-COVID
- Not applicable (device/behavioral)
PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID
- Observational study
Cognitive-Sensorimotor Function in Long-COVID
- Phase 1
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
- Observational study
Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)
- Not applicable (device/behavioral)
Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial
- Observational study
Mitochondrial Function in Peripheral Blood Mononuclear Cells, Muscle, and Skin of Long COVID Patients
- Not applicable (device/behavioral)
Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition
- Phase 2
Immunoadsorption in Autoimmune Long COVID
- Phase 2
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
- Observational study
Development of Voice Biomarkers of Frequent COVID-19 and Long Covid-related Symptoms Based on Data From Users of the Long COVID Companion App
- Early phase 1
Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)
- Not applicable (device/behavioral)
Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
- Phase 4
A Trial of Shengmai Liquid for Long COVID Fatigue.
See all 114 on ClinicalTrials.gov →
General information only, not medical advice. Trial listings are written by sponsors; eligibility and contacts are on each official listing.